GlaxoSmithKline (GSK) has described media reports of an overall review of operations in Ireland as “completely inaccurate”, telling in-PharmaTechnologist that the exercise only covers the plant in Cork.
GSK and Walvax have entered into a long-term joint venture (JV) to serve the Chinese vaccine market, with the big pharma transferring technology to enable local production and building a manufacturing plant.
UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.
GlaxoSmithKline (GSK) is to take a 16 per cent stake in Aspen in exchange for a manufacturing facility and eight medicines, building on the companies’ relationship and the big pharma’s profile in Africa.
The pharmaceutical industry in the UK faces tougher legislation on
the disclosure of adverse events in clinical trials following the
MHRA's thwarted attempt to prosecute GlaxoSmithKline for allegedly
withholding information about...